T65.5X1

Clinical Causes: Accidental ingestion or exposure to nitroglycerin-based medications. Unintentional inhalation of vapors or aerosols containing nitric esters. Accidental skin contact or absorption of nitric acid esters during industrial work. Improper storage or handling of chemicals containing nitric acids or their esters. Use of contaminated or counterfeit medications containing these substances.

Key Symptoms: Severe headache Dizziness or lightheadedness Nausea and vomiting Low blood pressure (hypotension) Rapid or irregular heartbeat Flushing or skin redness Blurred vision Weakness or fatigue Respiratory difficulties in severe cases

Diagnosis Path: Diagnosis involves a thorough review of the patient's medical history, exposure details, and clinical examination. Healthcare professionals might perform laboratory tests, including blood and urine analyses, to detect the presence of nitric acid esters or related metabolites. Additionally, vital signs, ECG monitoring, and blood pressure assessments are essential in evaluating the severity of toxicity and guiding treatment decisions.

Treatment Protocols: Management of accidental toxicity from nitroglycerin and nitric acid esters focuses on prompt stabilization and removal of the toxic substance. Typical interventions include: - Supportive care such as oxygen therapy and intravenous fluids. - Monitoring vital signs closely. - Administration of medications to counteract symptoms, like vasopressors for low blood pressure. - In some cases, activated charcoal may be used if ingestion occurred recently. - Specific antidotes are generally not available; hence, supportive and symptomatic treatments are primary. - Continuous monitoring in a medical facility until symptoms subside is advisable. - Prevention strategies involve safe handling, proper storage, and adherence to safety guidelines when working with chemicals containing nitric acids or esters.